It has been proposed that the upregulation of ICOS/ICOSLG expression could potentially play a role in the advancement of atypical cytology, transitioning from low-grade colorectal lesions to high-grade lesions and ultimately leading to CRC. This evidence concerns the gene ICOSLG and colorectal carcinoma.